Cipla stock has October 27 results ahead with 11.00 percent margin
Published on 10/16/2026 at 16:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResults date and valuation
- Cipla is scheduled to release Q2 FY27 results on October 27, 2026.
- Cipla's first-quarter net margin was 11.00 percent, down from 19.00 percent.
- Cipla stock costs INR 1,325.10 at 3:29 p.m. IST on October 16, 2026, down 0.22 percent versus the NSE prior close of INR 1,328.00.
- Cipla's price-to-earnings ratio is 31.78 as of October 16, 2026.
Cipla Limited is scheduled to release its second-quarter fiscal 2027 results on October 27, 2026, according to ScanX News. The upcoming report follows first-quarter fiscal 2027 net income of INR 7.89 billion, while the net margin was 11.00 percent versus 19.00 percent a year earlier, according to Investing.com. Cipla stock stood at INR 1,325.10 at 3:29 p.m. IST on October 16, 2026, down 0.22 percent from the NSE prior close of INR 1,328.00.
Profit pressure sets the comparison
The June 2026 quarter delivered revenue of INR 71.19 billion, up 3.50 percent from INR 68.40 billion in the same quarter a year earlier. Net income declined 39.00 percent from INR 13.00 billion to INR 7.89 billion over the same comparison, leaving the October report to clarify whether margin pressure is easing.
Stock position on October 16
Cipla traded between INR 1,315.10 and INR 1,337.50 during the session. Its 52-week range was INR 1,165.70 to INR 1,673.00, placing the latest price 20.80 percent below the high and 13.68 percent above the low. Trading volume reached 850,284 shares against an average of 1,018,453 shares.
The stock was down 0.22 percent on October 16, while its one-year performance was minus 15.57 percent. The market value stood at INR 1.1 trillion, and the price-to-earnings ratio was 31.78. The dividend yield was 0.01 percent.
Comparison with peers
Cipla (NSE, INR): minus 0.22 percent, P/E 31.78, market capitalization INR 1.1 trillion
Sun Pharmaceutical Industries (NSE, INR): minus 0.29 percent, P/E 34.89, market capitalization INR 4.2 trillion
Dr. Reddy's Laboratories (NSE, INR): plus 1.17 percent, P/E 31.05, market capitalization INR 1.0 trillion
October 27 results date
The company is scheduled to publish unaudited results for the quarter and half year ended September 30, 2026, on October 27, 2026. The earnings call is scheduled for 4:00 p.m. IST that day, according to ScanX News.
What the next report must clarify
The central measurement is the relationship between revenue growth and profitability. Cipla's first-quarter revenue increased 3.50 percent year over year, while net income fell 39.00 percent, making the next margin figure more important than sales growth alone.
Cipla stock facts
- Company: Cipla Limited
- ISIN: INE059A01026
- Ticker: CIPL
- Primary exchange: NSE
- Price NSE (as of October 16, 2026, 3:29 p.m. IST): INR 1,325.10
- Change versus NSE prior close: minus 0.22 percent
- NSE prior close (October 15, 2026): INR 1,328.00
- Market capitalization: INR 1.1 trillion (as of October 16, 2026)
- 52-week range: INR 1,165.70-1,673.00 (as of October 16, 2026)
- Sector / Industry: Healthcare / Pharmaceuticals
- Next earnings date: October 27, 2026
Market context: Market report BSE Sensex.
